Patients affected by Eosinophilic Granulomatosis with Polyangiitis (EGPA) display an increased risk of atherothrombotic events compared with the general population. An increased frequency of subclinical markers of atherosclerosis has been observed in other anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), but no specific study focused on EGPA. We therefore evaluated subclinical atherosclerosis in EGPA patients and in a control population.
Evidence of subclinical atherosclerosis in Eosinophilic Granulomatosis with Polyangiitis (EGPA)
Bello, FedericaPrimo
;Emmi, Giacomo
Penultimo
;
2023-01-01
Abstract
Patients affected by Eosinophilic Granulomatosis with Polyangiitis (EGPA) display an increased risk of atherothrombotic events compared with the general population. An increased frequency of subclinical markers of atherosclerosis has been observed in other anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), but no specific study focused on EGPA. We therefore evaluated subclinical atherosclerosis in EGPA patients and in a control population.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
keac427.pdf
Accesso chiuso
Tipologia:
Documento in Versione Editoriale
Licenza:
Copyright Editore
Dimensione
263.79 kB
Formato
Adobe PDF
|
263.79 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
